Reports
Sale
Global Wellness Genomics Market Share, Analysis, Forecast: By Type: Predictive Testing, Consumer Genomics, Others; By Setting Type: DTC, Professional; By Application: Breast and Ovarian Cancer Screening, Cardiovascular Screening, Diabetic Screening and Monitoring, Others; Regional Analysis; Market Dynamics; Competitive Landscape; 2024-2032
Global Wellness Genomics Market Outlook
The global wellness genomics market attained a value of USD 5.44 billion in 2023. The wellness genomics market is further expected to grow in the forecast period of 2024-2032 at a CAGR of 15.1% to reach USD 19.30 billion by 2032.
The increased awareness of healthcare and the changing preferences of the population for a healthier lifestyle have contributed to the growth of the wellness genomics industry.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Market Segmentation
Genomics or genome sequencing had been previously synonymous with the threat of a disease or more death. With genome sequencing becoming cheaper and more affordable, numerous bioinformatics companies offer services that use DNA-based information to treat ageing, manage or detect wellness, or even the sports a person must pursue in accordance with genetic information, and eventually attempt to combine a healthy approach to his life. Genetic data can be used for a substantially healthy life. This is now referred to as wellness genomics.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Based on type, the wellness genomics market can be divided into predictive testing and consumer genomics.
Predictive testing can be further divided into:
- Genetic Susceptibility Test
- Predictive Diagnostics
- Population Screening Programs
Consumer genomics is further segmented into:
- Wellness Genetics
- Nutria Genetics
- Skin and Metabolism Genetics
- Others
The setting type is divided into the following:
- DTC
- Professional
The wellness genomics market can be broadly categorised based on its applications into:
- Breast and Ovarian Cancer Screening
- Cardiovascular Screening
- Diabetic Screening and Monitoring
- Colon Cancer Screening
- Alzheimer’s Disease
- Prostate Cancer Screening
- Orthopaedic and Musculoskeletal Screening
- Other Cancer Screening
- Other Diseases Screening
The EMR report looks into the regional wellness genomics markets like North America, Latin America, Europe, the Middle East and Africa, and the Asia Pacific.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Market Analysis
The increased awareness of healthcare and the changing population preferences to a healthy lifestyle contributed to the growth of the predictive genetics research and the wellness genomics industry. The global genetic testing and wellness genomics market are expected to be driven by factors such as increased public and private regulatory attention to public health, improved genetic test efficacy and efficiency, the prevalence of genetically modified chronic diseases, and diseases such as Parkinson’s and cystic fibroids. In addition, the growing need to comprehend one’s family history also drives the global market. Strict regulatory regulations and ethics to allow genetic testing could, however, restrict the market growth.
Competitive Landscape
The report presents a detailed analysis of the following key players in the global wellness genomics market, looking into their capacity, market shares, and latest developments like capacity expansions, plant turnarounds, and mergers and acquisitions:
- F. Hoffmann-La Roche Ltd.
- Abbott Laboratories
- Thermo Fisher Scientific, Inc.
- Agilent Technologies, Inc.
- Bio-Rad Laboratories, Inc.
- Illumina, Inc.
- QIAGEN N.V.
- Myriad Genetics, Inc.
- CooperSurgical, Inc.
- Others
The EMR report gives an in-depth insight into the market by providing a SWOT analysis as well as an analysis of Porter’s Five Forces model.
Key Highlights of the Report
| REPORT FEATURES | DETAILS |
| Base Year | 2023 |
| Historical Period | 2017-2023 |
| Forecast Period | 2024-2032 |
| Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
| Breakup by Type |
|
| Breakup by Setting Type |
|
| Breakup by Application |
|
| Breakup by Region |
|
| Market Dynamics |
|
| Competitive Landscape |
|
| Companies Covered |
|
| Report Price and Purchase Option | Explore our purchase options that are best suited to your resources and industry needs. |
| Delivery Format | Delivered as an attached PDF and Excel through email, with an option of receiving an editable PPT, according to the purchase option. |
*At Expert Market Research, we strive to always give you current and accurate information. The numbers depicted in the description are indicative and may differ from the actual numbers in the final EMR report.
1 Preface
2 Report Coverage – Key Segmentation and Scope
3 Report Description
3.1 Market Definition and Outlook
3.2 Properties and Applications
3.3 Market Analysis
3.4 Key Players
4 Key Assumptions
5 Executive Summary
5.1 Overview
5.2 Key Drivers
5.3 Key Developments
5.4 Competitive Structure
5.5 Key Industrial Trends
6 Snapshot
6.1 Global
6.2 Regional
7 Opportunities and Challenges in the Market
8 Global Wellness Genomics Market Analysis
8.1 Key Industry Highlights
8.2 Global Wellness Genomics Historical Market (2018-2023)
8.3 Global Wellness Genomics Market Forecast (2024-2032)
8.4 Global Wellness Genomics Market by Type
8.4.1 Predictive Testing
8.4.1.1 Historical Trend (2018-2023)
8.4.1.2 Forecast Trend (2024-2032)
8.4.2 Consumer Genomics
8.4.2.1 Historical Trend (2018-2023)
8.4.2.2 Forecast Trend (2024-2032)
8.4.3 Others
8.5 Global Wellness Genomics Market by Setting Type
8.5.1 DTC
8.5.1.1 Historical Trend (2018-2023)
8.5.1.2 Forecast Trend (2024-2032)
8.5.2 Professional
8.5.2.1 Historical Trend (2018-2023)
8.5.2.2 Forecast Trend (2024-2032)
8.6 Global Wellness Genomics Market by Application
8.6.1 Breast and Ovarian Cancer Screening
8.6.1.1 Historical Trend (2018-2023)
8.6.1.2 Forecast Trend (2024-2032)
8.6.2 Cardiovascular Screening
8.6.2.1 Historical Trend (2018-2023)
8.6.2.2 Forecast Trend (2024-2032)
8.6.3 Diabetic Screening and Monitoring
8.6.3.1 Historical Trend (2018-2023)
8.6.3.2 Forecast Trend (2024-2032)
8.6.4 Colon Cancer Screening
8.6.4.1 Historical Trend (2018-2023)
8.6.4.2 Forecast Trend (2024-2032)
8.6.5 Alzheimer’s Disease
8.6.5.1 Historical Trend (2018-2023)
8.6.5.2 Forecast Trend (2024-2032)
8.6.6 Prostate Cancer Screening
8.6.6.1 Historical Trend (2018-2023)
8.6.6.2 Forecast Trend (2024-2032)
8.6.7 Orthopedic and Musculoskeletal Screening
8.6.7.1 Historical Trend (2018-2023)
8.6.7.2 Forecast Trend (2024-2032)
8.6.8 Other Cancer Screening
8.6.9 Other Diseases Screening
8.7 Global Wellness Genomics Market by Region
8.7.1 North America
8.7.1.1 Historical Trend (2017-2021)
8.7.1.2 Forecast Trend (2022-2027)
8.7.2 Europe
8.7.2.1 Historical Trend (2017-2021)
8.7.2.2 Forecast Trend (2022-2027)
8.7.3 Asia Pacific
8.7.3.1 Historical Trend (2017-2021)
8.7.3.2 Forecast Trend (2022-2027)
8.7.4 Latin America
8.7.4.1 Historical Trend (2017-2021)
8.7.4.2 Forecast Trend (2022-2027)
8.7.5 Middle East and Africa
8.7.5.1 Historical Trend (2017-2021)
8.7.5.2 Forecast Trend (2022-2027)
9 North America Wellness Genomics Market Analysis
9.1 United States of America
9.1.1 Historical Trend (2017-2021)
9.1.2 Forecast Trend (2022-2027)
9.2 Canada
9.2.1 Historical Trend (2017-2021)
9.2.2 Forecast Trend (2022-2027)
10 Europe Wellness Genomics Market Analysis
10.1 United Kingdom
10.1.1 Historical Trend (2017-2021)
10.1.2 Forecast Trend (2022-2027)
10.2 Germany
10.2.1 Historical Trend (2017-2021)
10.2.2 Forecast Trend (2022-2027)
10.3 France
10.3.1 Historical Trend (2017-2021)
10.3.2 Forecast Trend (2022-2027)
10.4 Italy
10.4.1 Historical Trend (2017-2021)
10.4.2 Forecast Trend (2022-2027)
10.5 Others
11 Asia Pacific Wellness Genomics Market Analysis
11.1 China
11.1.1 Historical Trend (2017-2021)
11.1.2 Forecast Trend (2022-2027)
11.2 Japan
11.2.1 Historical Trend (2017-2021)
11.2.2 Forecast Trend (2022-2027)
11.3 India
11.3.1 Historical Trend (2017-2021)
11.3.2 Forecast Trend (2022-2027)
11.4 ASEAN
11.4.1 Historical Trend (2017-2021)
11.4.2 Forecast Trend (2022-2027)
11.5 Australia
11.5.1 Historical Trend (2017-2021)
11.5.2 Forecast Trend (2022-2027)
11.6 Others
12 Latin America Wellness Genomics Market Analysis
12.1 Brazil
12.1.1 Historical Trend (2017-2021)
12.1.2 Forecast Trend (2022-2027)
12.2 Argentina
12.2.1 Historical Trend (2017-2021)
12.2.2 Forecast Trend (2022-2027)
12.3 Mexico
12.3.1 Historical Trend (2017-2021)
12.3.2 Forecast Trend (2022-2027)
12.4 Others
13 Middle East and Africa Wellness Genomics Market Analysis
13.1 Saudi Arabia
13.1.1 Historical Trend (2017-2021)
13.1.2 Forecast Trend (2022-2027)
13.2 United Arab Emirates
13.2.1 Historical Trend (2017-2021)
13.2.2 Forecast Trend (2022-2027)
13.3 Nigeria
13.3.1 Historical Trend (2017-2021)
13.3.2 Forecast Trend (2022-2027)
13.4 South Africa
13.4.1 Historical Trend (2017-2021)
13.4.2 Forecast Trend (2022-2027)
13.5 Others
14 Market Dynamics
14.1 SWOT Analysis
14.1.1 Strengths
14.1.2 Weaknesses
14.1.3 Opportunities
14.1.4 Threats
14.2 Porter’s Five Forces Analysis
14.2.1 Supplier’s Power
14.2.2 Buyer’s Power
14.2.3 Threat of New Entrants
14.2.4 Degree of Rivalry
14.2.5 Threat of Substitutes
14.3 Key Indicators for Demand
14.4 Key Indicators for Price
15 Competitive Landscape
15.1 Market Structure
15.2 Company Profiles
15.2.1 F. Hoffmann-La Roche Ltd.
15.2.1.1 Company Overview
15.2.1.2 Product Portfolio
15.2.1.3 Demographic Reach and Achievements
15.2.1.4 Certifications
15.2.2 Abbott Laboratories
15.2.2.1 Company Overview
15.2.2.2 Product Portfolio
15.2.2.3 Demographic Reach and Achievements
15.2.2.4 Certifications
15.2.3 Thermo Fisher Scientific, Inc.
15.2.3.1 Company Overview
15.2.3.2 Product Portfolio
15.2.3.3 Demographic Reach and Achievements
15.2.3.4 Certifications
15.2.4 Agilent Technologies, Inc.
15.2.4.1 Company Overview
15.2.4.2 Product Portfolio
15.2.4.3 Demographic Reach and Achievements
15.2.4.4 Certifications
15.2.5 Bio-Rad Laboratories, Inc.
15.2.5.1 Company Overview
15.2.5.2 Product Portfolio
15.2.5.3 Demographic Reach and Achievements
15.2.5.4 Certifications
15.2.6 Illumina, Inc.
15.2.6.1 Company Overview
15.2.6.2 Product Portfolio
15.2.6.3 Demographic Reach and Achievements
15.2.6.4 Certifications
15.2.7 QIAGEN N.V.
15.2.7.1 Company Overview
15.2.7.2 Product Portfolio
15.2.7.3 Demographic Reach and Achievements
15.2.7.4 Certifications
15.2.8 Myriad Genetics, Inc.
15.2.8.1 Company Overview
15.2.8.2 Product Portfolio
15.2.8.3 Demographic Reach and Achievements
15.2.8.4 Certifications
15.2.9 CooperSurgical, Inc.
15.2.9.1 Company Overview
15.2.9.2 Product Portfolio
15.2.9.3 Demographic Reach and Achievements
15.2.9.4 Certifications
15.2.10 Others
16 Key Trends and Developments in the Market
List of Key Figures and Tables
1. Global Wellness Genomics Market: Key Industry Highlights, 2018 and 2032
2. Global Wellness Genomics Historical Market: Breakup by Type (USD Billion), 2018-2023
3. Global Wellness Genomics Market Forecast: Breakup by Type (USD Billion), 2024-2032
4. Global Wellness Genomics Historical Market: Breakup by Setting Type (USD Billion), 2018-2023
5. Global Wellness Genomics Market Forecast: Breakup by Setting Type (USD Billion), 2024-2032
6. Global Wellness Genomics Historical Market: Breakup by Application (USD Billion), 2018-2023
7. Global Wellness Genomics Market Forecast: Breakup by Application (USD Billion), 2024-2032
8. Global Wellness Genomics Historical Market: Breakup by Region (USD Billion), 2018-2023
9. Global Wellness Genomics Market Forecast: Breakup by Region (USD Billion), 2024-2032
10. North America Global Wellness Genomics Historical Market: Breakup by Country (USD Billion), 2018-2023
11. North America Global Wellness Genomics Market Forecast: Breakup by Country (USD Billion), 2024-2032
12. Europe Global Wellness Genomics Historical Market: Breakup by Country (USD Billion), 2018-2023
13. Europe Global Wellness Genomics Market Forecast: Breakup by Country (USD Billion), 2024-2032
14. Asia Pacific Global Wellness Genomics Historical Market: Breakup by Country (USD Billion), 2018-2023
15. Asia Pacific Global Wellness Genomics Market Forecast: Breakup by Country (USD Billion), 2024-2032
16. Latin America Global Wellness Genomics Historical Market: Breakup by Country (USD Billion), 2018-2023
17. Latin America Global Wellness Genomics Market Forecast: Breakup by Country (USD Billion), 2024-2032
18. Middle East and Africa Global Wellness Genomics Historical Market: Breakup by Country (USD Billion), 2018-2023
19. Middle East and Africa Global Wellness Genomics Market Forecast: Breakup by Country (USD Billion), 2024-2032
20. Global Wellness Genomics Market Structure
Key Questions Answered in the Report
In 2023, the global wellness genomics market attained a value of nearly USD 5.44 billion.
The market is projected to grow at a CAGR of 15.1% between 2024 and 2032.
The market is estimated to witness a healthy growth in the forecast period of 2024-2032 to reach about USD 19.30 billion by 2032.
The major drivers of the market are changing consumer preferences, increased public and private regulatory attention to public health, and the prevalence of genetically modified chronic diseases and conditions such as Parkinson’s and cystic fibroids.
The key trends guiding the growth of the market includes the growing awareness regarding genetic health, improved genetic test efficacy and efficiency, and improvements in healthcare infrastructure.
The major regions in the market are North America, Latin America, the Middle East and Africa, Europe, and the Asia Pacific.
The leading types of wellness genomics in the market include predictive testing and consumer genomics, among others.
The major setting types in the market are DTC and professional.
The significant applications of wellness genomics in the market are breast and ovarian cancer screening, cardiovascular screening, diabetic screening and monitoring, colon cancer screening, Alzheimer’s disease, prostate cancer screening, orthopaedic and musculoskeletal screening, other cancer screening, and other diseases screening.
The major players in the global wellness genomics market are F. Hoffmann-La Roche Ltd., Abbott Laboratories, Thermo Fisher Scientific, Inc., Agilent Technologies, Inc., Bio-Rad Laboratories, Inc., Illumina, Inc., QIAGEN N.V., Myriad Genetics, Inc., and CooperSurgical, Inc., among others.
Analyst Review
The global wellness genomics market attained a value of USD 5.44 billion in 2023, driven by the rising awareness of healthcare. Aided by the changing lifestyles to a healthier one, the market is expected to witness a further growth in the forecast period of 2024-2032, growing at a CAGR of 15.1%. The market is projected to reach USD 19.30 billion by 2032.
EMR’s meticulous research methodology delves deep into the market, covering the macro and micro aspects of the industry. Based on its types, the wellness genomics industry can be segmented into predictive testing and consumer genomics. On the basis of setting types, the industry is bifurcated into DTC and professional. On the basis of applications, the industry is divided into breast and ovarian cancer screening, cardiovascular screening, diabetic screening and monitoring, colon cancer screening, Alzheimer’s disease, prostate cancer screening, orthopaedic and musculoskeletal screening, other cancer screening, and other diseases screening. The major regional markets for wellness genomics are North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa. The key players in the above market include F. Hoffmann-La Roche Ltd., Abbott Laboratories, Thermo Fisher Scientific, Inc., Agilent Technologies, Inc., Bio-Rad Laboratories, Inc., Illumina, Inc., QIAGEN N.V., Myriad Genetics, Inc., and CooperSurgical, Inc., among others.
EMR’s research methodology uses a combination of cutting-edge analytical tools and the expertise of their highly accomplished team, thus, providing their customers with market insights that are accurate, actionable, and help them remain ahead of their competition.
Purchase Options 10% off
Call us
Purchase Full Report
Mini Report
$ 2969
$2699
-
Selected Sections, One User
-
Printing Not Allowed
-
Email Delivery in PDF
-
Free Limited Customisation -
Post Sales Analyst Support -
50% Discount on Next Update
Single User License
$ 5499
$4999
-
All Sections, One User
-
One Print Allowed
-
Email Delivery in PDF
-
Free Limited Customisation -
Post Sales Analyst Support -
50% Discount on Next Update
Five User License
$ 6599
$5999
-
All Sections, Five Users
-
Five Prints Allowed
-
Email Delivery in PDF
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Corporate License
$ 7699
$6999
-
All Sections, Unlimited Users
-
Unlimited Prints Allowed
-
Email Delivery in PDF + Excel
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Any Question? Speak With An Analyst
View A Sample
Did You Miss Anything, Ask Now
Why Expert Market Research?
Right People
We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.
Right Methodology
We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.
Right Price
We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.
Right Support
Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.
NEWSLETTER